Tilray TLRY Stock Analysis and why TLRY stock is plummeting – what’s next for TLRY stock

Cannabis REIT Reports Default Resolution

Innovative Industrial Properties Reports Resolution to Default by PharmaCann SAN DIEGO–(BUSINESS WIRE)–Innovative Industrial Properties, Inc. (IIP), the first and only real estate company on the

January 30, 2025

MorphoSys AG Reports First Quarter 2024 Financial Results – Biotech Investments

EQS-News: MorphoSys AG / Key word(s): Quarterly / Interim Statement MorphoSys AG Reports First Quarter 2024 Financial Results 29.04.2024 / 22:01 CET/CEST The issuer is

April 30, 2024

Bristol Myers scores accelerated approval in more blood cancers for CAR-T therapy Breyanzi

Bristol Myers Squibb is bringing its CAR-T cell therapy to adults with relapsed or refractory chronic lymphocytic leukemia or small lymphocytic lymphoma, thanks to an

March 16, 2024

Supercharge Your Portfolio with Future Health Stocks!

Join us for Profitable Insights & Expert Tips!

With expert analysis, comprehensive market coverage, and actionable insights, our newsletter equips you with the knowledge & tools necessary to make informed decisions & maximize your potential returns in the dynamic world of future health stocks.